The typical research protocol involves subcutaneous injection of 5-10 mg daily for 10-20 consecutive days, repeated in 4-6 month cycles
It is made up ofglycine, glutamine, and cysteine
The running buffer was HBS EP+ buffer (10 mM Hepes pH 7.4, 150 mM NaCl, 3 mM EDTA and 0.05% (v/v) SurfactantP20) containing 0.1% DMSO
doi: 10.1016/j.bbi.2017.01.007 91 SmithJFritzELKerrJRCleareAJWesselySMatteyDL
Combination Formulation Strategies GHK-Cu demonstrates compatibility with numerous cosmeceutical and pharmaceutical actives, enabling rational combination formulations targeting multiple aging or healing pathways
For example, more than a decade ago, researchers found that the CD44 gene was likely involved in the risk of liver damage from high doses of acetaminophen